Panobinostat and Ruxolitinib In MyElofibrosis (PRIME Trial)
Clinical trial NCT01693601 · COMPLETED
Trial details
- NCT number
- NCT01693601
- Sponsor
- John Mascarenhas
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2018-05-18
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.